Skip to content
Trial Eligibility
Menu

REcovery From DEXmedetomidine-induced Unconsciousness

NCT06003127

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

This pilot study in healthy volunteers aims to determine if biological sex has an impact on recovery from dexmedetomidine-induced unconsciousness, and if transcranial magnetic stimulation combined with electroencephalography (TMS-EEG) can be used to measure brain complexity during dexmedetomidine sedation without arousing study participants.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Anesthesia
  • Healthy
  • Consciousness, Level Altered

Eligibility basics and study details

Study type
Interventional
Phase
Not applicable
Ages
18 to 65 years
Sex
All
Healthy volunteers
Accepted
Sponsor
Massachusetts General Hospital
Last updated on ClinicalTrials.gov
January 22, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Massachusetts · 1

  • Massachusetts General Hospital · Boston, MA

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.